Feigenberg S - Search Results

1

Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.

Pollack A, Hanlon A, Horwitz EM, Feigenberg S, Uzzo RG, Price RA. Pollack A, et al. Among authors: feigenberg s. World J Urol. 2003 Sep;21(4):200-8. doi: 10.1007/s00345-003-0356-x. Epub 2003 Sep 5. World J Urol. 2003. PMID: 12961097 Review.

2

Radiation therapy for giant cell tumors of bone.

Feigenberg SJ, Marcus Jr RB, Zlotecki RA, Scarborough MT, Berrey BH, Enneking WF. Feigenberg SJ, et al. Clin Orthop Relat Res. 2003 Jun;(411):207-16. doi: 10.1097/01.blo.0000069890.31220.b4. Clin Orthop Relat Res. 2003. PMID: 12782877

3

Prostate cancer radiotherapy dose response: an update of the fox chase experience.

Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Uzzo RG, Hanks GE. Pollack A, et al. J Urol. 2004 Mar;171(3):1132-6. doi: 10.1097/01.ju.0000111844.95024.74. J Urol. 2004. PMID: 14767286

4

A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy.

Chism DB, Hanlon AL, Horwitz EM, Feigenberg SJ, Pollack A. Chism DB, et al. Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):380-5. doi: 10.1016/j.ijrobp.2003.10.059. Int J Radiat Oncol Biol Phys. 2004. PMID: 15145151

5

The treatment of non-metastatic prostate cancer with external beam radiation therapy.

Horwitz EM, Feigenberg SJ, Uzzo RG. Horwitz EM, et al. Among authors: feigenberg sj. Minerva Urol Nefrol. 2004 Jun;56(2):173-88. Minerva Urol Nefrol. 2004. PMID: 15195025 Review.

6

Androgen suppression plus radiation therapy for prostate cancer.

Horwitz EM, Feigenberg SJ, Pollack A, Hanks GE, Uzzo RG. Horwitz EM, et al. JAMA. 2004 Nov 3;292(17):2084-5; author reply 2085. doi: 10.1001/jama.292.17.2084-b. JAMA. 2004. PMID: 15523065 No abstract available.

7

In regard to Selek et al. erectile dysfunction and radiation dose to penile base structures: a lack of correlation. IJROBP 2004;59:1039-1046.

Buyyounouski MK, Hanlon AL, Price RA Jr, Horwitz EM, Feigenberg SJ, Pollack A. Buyyounouski MK, et al. Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1664-5; author reply 1666. doi: 10.1016/j.ijrobp.2004.09.011. Int J Radiat Oncol Biol Phys. 2004. PMID: 15590205 No abstract available.

8

Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.

Kramer NM, Horwitz EM, Cheng J, Ridge JA, Feigenberg SJ, Cohen RB, Nicolaou N, Sherman EJ, Babb JS, Damsker JA, Langer CJ. Kramer NM, et al. Among authors: feigenberg sj. Head Neck. 2005 May;27(5):406-14. doi: 10.1002/hed.20163. Head Neck. 2005. PMID: 15719391 Clinical Trial.

9

Stereotactic IMRT for prostate cancer: setup accuracy of a new stereotactic body localization system.

Wang L, Jacob R, Chen L, Ma C, Movsas B, Feigenberg S, Konski A. Wang L, et al. Among authors: feigenberg s. J Appl Clin Med Phys. 2004 Spring;5(2):18-28. doi: 10.1120/jacmp.v5i2.1947. Epub 2004 Apr 1. J Appl Clin Med Phys. 2004. PMID: 15738910 Free PMC article. Clinical Trial.

10

Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.

Wang L, Movsas B, Jacob R, Fourkal E, Chen L, Price R, Feigenberg S, Konski A, Pollack A, Ma C. Wang L, et al. Among authors: feigenberg s. J Appl Clin Med Phys. 2004 Spring;5(2):29-41. doi: 10.1120/jacmp.v5i2.1989. Epub 2004 Apr 1. J Appl Clin Med Phys. 2004. PMID: 15738911 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters